114 results
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
GLP-1 Agonists ... Weekly Ozempic (Semaglutide ... -1 Agonists are ... being studied (semaglutide ... #GLP1 #Agonists
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
) - First Oral GLP ... -1 Agonist Dosing ... agonist! ... agonists. ... GLP1 agonists are
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... the pancreas (GLP ... injection • Semaglutide ... dulaglutide, and semaglutide ... #Receptor #Agonists
GLP-1 Medications: Ozempic vs. Trulicib (semaglutide vs. dulaglutide) 

From my experience, Ozempic and Trulicity are the
GLP-1 Medications ... Trulicib (semaglutide ... commonly used GLP1 ... trial of Ozempic (semaglutide ... Ozempic #Trulicib #semaglutide
Algorithm for prescribing SGLT2 inhibitors and GLP1 agonists

This algorithm prioritizes the prescription of SGLT2i and GLP-1
inhibitors and GLP1 ... agonists This ... of SGLT2i and GLP ... -1 Receptor Agonists ... #SGLT2 #GLP1 #prescribing
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
- PPAR gamma agonist ... INCRETIN AGENTS • GLP ... -1 agonists ... - Prevents GLP
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Meglitinides • GLP ... -1 Receptor Agonists
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Sulfonylureas GLP ... -1 receptor agonists
Classification of Adrenergic Receptor Agonists (sympathomymetics)

#Adrenergic #Receptor #Agonists #sympathomymetics #Classification #Pharmacology
Adrenergic Receptor Agonists ... Adrenergic #Receptor #Agonists
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
mu-opioid receptor agonist ... displacing full agonists ... As a partial agonist ... However, full agonists ... As a partial agonist